Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc (APLS) Financials

APLS Apellis Pharmaceuticals Inc

34.255

-0.125 (-0.36%)

Last Updated: 14:32:56

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-82.686	-48.678	-66.121	-102.806	-51.099	-81.023	-79.437	-67.869
Return on Equity (%)	-92.307	-59.056	-82.282	-312.195	-288.855	-370.198	-353.928	-288.495
Return on Invested Capital (%)	-93.159	-51.036	-70.976	-159.27	-59.649	-119.154	-197.476	-194.822
Operating Margin (%)	N/A	N/A	N/A	N/A	-124.914	-1100.853	-820.552	-125.297
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-137.594	-1121.275	-864.697	-132.537
Book Value Per Share	-3.797	2.959	2.86	0.608	2.687	2.037	1.534	1.642
Earnings Per Share	-1.509	-1.013	-2.266	-5.414	-4.53	-7.653	-5.888	-4.436
Cash Per Share	1.383	3.49	3.132	6.254	7.432	6.564	4.981	2.964
Working Capital Per Share	1.32	3.486	3.295	5.461	10.362	7.098	4.982	4.378
Operating Profit Per Share	N/A	N/A	N/A	N/A	3.292	0.68	0.63	2.868
EBIT Per Share	-1.509	-1.013	-2.266	-5.414	-4.506	-7.649	-5.881	-4.418
EBITDA Per Share	-1.509	-1.013	-2.266	-5.414	-4.506	-7.649	-5.881	-4.418
Free Cash Flow Per Share	-1.509	-1.013	-2.266	-5.388	-4.467	-7.656	-5.888	-4.444

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	17.98M	50.33M	56.28M	56.28M	76.13M	97.52M	110.77M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	110.77M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-379.001	N/A	N/A	N/A	-34.404	N/A	N/A
Net Profit Margin (%)	N/A	-396.419	N/A	N/A	N/A	-38.545	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	4.28B
Price to Earnings Ratio	-8.14
Price to Sales Ratio	10.78
Price to Cash Ratio	12.18
Price to Book Ratio	21.99
Dividend Yield	-

Share Statistics

Shares Outstanding	124.39M
Average Volume (1 week)	2.27M
Average Volume (1 Month)	2.39M
52 Week Change	-42.29%
52 Week High	73.80
52 Week Low	24.34

More Ratios Coming Soon!

Apellis Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions